Functionalized dendrimer-like hybrid silica nanoparticles with hierarchical pores are designed and synthesized. The unique structure, large surface area, and excellent biocompability render such materials attractive nanocarriers for the advanced delivery of various sized drugs and genes simultaneously.
CeO2/g-C3N4 n–n type heterojunction was successfully constructed via a facile in situ co-pyrolysis route by employing Ce(IO3)3 and melamine as precursors. It exhibits high photo-induced oxidation and reduction properties for degradation of phenol, NO removal and hydrogen evolution.
Dendritic silica micro-/nanoparticles with center-radial pore structures, a kind of newly created porous material, have attracted considerable attention owing to their unique open three-dimensional dendritic superstructures with large pore channels and highly accessible internal surface areas compared with conventional mesoporous silica nanoparticles (MSNs). They are very promising platforms for a variety of applications in catalysis and nanomedicine. In this review, their unique structural characteristics and properties are first analyzed, then novel and interesting synthesis methods associated with the possible formation mechanisms are summarized to provide material scientists some inspiration for the preparation of this kind of dendritic particles. Subsequently, a few examples of interesting applications are presented, mainly in catalysis, biomedicine, and other important fields such as for sacrificial templates and functional coatings. The review is concluded with an outlook on the prospects and challenges in terms of their controlled synthesis and potential applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.